clevudine + tenofovir placebo

This refers to a clinical trial arm in which patients receive active clevudine and a placebo for tenofovir, rather than both drugs as an active combination. Clevudine is an oral pyrimidine nucleoside analog with potent antiviral activity against hepatitis B virus (HBV). It acts as a non-chain terminating inhibitor of HBV DNA polymerase, leading to suppression of viral replication. Tenofovir placebo is an inert substance used in clinical trials to mimic the administration of tenofovir without providing its pharmacological effects. This combination is typically used as a control group in studies comparing the efficacy and safety of clevudine monotherapy versus combination therapy with tenofovir or other agents for chronic hepatitis B infection[5][6].